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Postoperative analgesiaAbstract Background: N-methyl-D-aspartate (NMDA) receptors play a major role in central
nociceptive transmission. Recent studies identiﬁed NMDA receptors peripherally. Magnesium
(Mg) has antinociceptive effects due to its antagonistic effect of NMDA receptors. The aim of this
randomized, double-blinded, placebo-controlled study was to assess the potential analgesic effect of
Mg when directly applied on the peripheral nerves, as well as to evaluate the efﬁcacy of Mg to facil-
itate the local anesthetic effect of Bupivacaine during peripheral nerve block.
Methods: Sixty patients, ASA physical status I, II & III, undergoing laser photocoagulation were
randomly divided into 2 equal groups. Both groups received femoral nerve block using nerve stim-
ulator. Patients of group A were given Bupivacaine and Magnesium sulfate, while patients of group
B were given Bupivacaine and saline. Pain was assessed using Visual analogue scale (VAS). The
duration of action of Bupivacaine was determined by assessing the duration of sensory block, as
well as, assessing the motor block of the quadriceps muscle in both groups. 75 mg of Diclofenac
sodium was administered IM as a rescue analgesic. The total dose of the Diclofenac sodium used
was recorded.
Results: The current study showed a signiﬁcantly shorter duration of action of Bupivacaine, with a
signiﬁcantly lower pain scores among patients of group A. On the other hand, bearable pain period
was signiﬁcantly shorter, and the total consumption of Diclofenac sodium in the 24 h postopera-
tively was signiﬁcantly higher in group B.
Conclusion: The current study concluded that the admixture of magnesium to bupivacaine pro-
vides a profound prolongation of the femoral nerve block, in addition to a signiﬁcant decrease in
170 H.A. ELShamaa et al.postoperative pain scores and total dose of rescue analgesia, with a longer bearable pain periods in
the ﬁrst postoperative day.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
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Magnesium (Mg) is the fourth most abundant cation in the
body and the second most abundant intracellular cation, it
activates many of the enzyme systems involved in energy
metabolism and acts as a natural calcium antagonist that reg-
ulates calcium access into the cell, in addition, Magnesium can
be considered as a physiological blocker of N-methyl-D-aspar-
tate (NMDA) receptors [1].
Magnesium (Mg) has antinociceptive effects due to its
antagonistic effect of NMDA receptors [2]. N-methyl-D-
aspartate (NMDA) receptors play a major role in central
nociceptive transmission, modulation and sensitization of
acute pain states [3]. In addition to their central location, re-
cent studies identiﬁed NMDA receptors peripherally in the
skin [4], muscles [5] and knee joints, and found that they
play a role in sensory transmission of noxious signals [6].
In its inactive state, the NMDA receptor is blocked by the
presence of a centrally positioned magnesium ion, the affer-
ent activity in nociceptor ﬁbers dislodges the central magne-
sium ion from the NMDA receptor, therefore allowing
calcium inﬂux into the cells [7].
The nerve stimulation is a well established method of nerve
location during applying a peripheral nerve block, generally, it
is accepted that the generated electrical current at the tip of the
insulated needle used in the block produces a motor response
before the needle enters the perineurium or even comes in di-
rect contact with the nerve, so reducing the incidence of nerve
trauma and intraneural injection [8,9]. We hypothesized that
the addition of Magnesium sulfate to local anesthetics during
peripheral nerve block would prolong the duration of the
block.
The aim of this randomized, double-blinded, placebo-con-
trolled study was to investigate the potential analgesic effect
of Magnesium sulfate and its possible efﬁcacy to prolong the
duration of action of Bupivacaine when administered together
for the femoral nerve block in patients undergoing laser photo-
coagulation of varicose veins of lower limbs.2. Patients and methods
After obtaining approval from the Clinical Research Ethics
Committee of Erfan and Bagedo General hospital and obtain-
ing informed consent, Sixty patients, ASA physical status I, II
& III, undergoing laser photocoagulation for varicose veins of
the lower limb were included in this study. The patients were
randomly divided into 2 equal groups: Group A patients
(n= 30) received femoral nerve block with Bupivacaine and
Mg and Group B patients (n= 30) received femoral nerve
block with Bupivacaine and saline. Inclusion criteria were as
follows: age >18 yr old; ability to consent; and ability to
understand and communicate, Exclusion criteria were cardio-
vascular, hepatic or renal dysfunction, neuromuscular diseases,
opioid or analgesic abuse, and prior treatment with calcium
channel blockers.All patients were premedicated with 5 mg midazolam I.M.
30 min before shifting to OR. After admission to OR, the stan-
dard monitors including noninvasive arterial blood pressure,
electrocardiography and pulse oximetry were applied. A 20
gauge intravenous catheter was inserted. With the patient in
supine position and an oxygen open facemask applied at 5
L/min, the inguinal region was exposed and scrubbed with
povidone iodine solution. The site of the needle insertion was
identiﬁed as a point 1 cm lateral to the femoral artery at the
level of the inguinal crease, and this site was anesthetized with
2 ml lidocaine 2%. A 21 gauge, 50-mm insulated stimulating
needle (Simplex A-B Braun Melsungen AG 34209 Melsungen
Germany) was used; it was connected to the nerve stimulator
(Pajunk nerve stimulator multistim sensor. Karl-Hall-Strabe
1-D-78187 Geisingen Germany), with the nerve stimulator
being connected to an ECG electrode applied on the lateral
side of the thigh of the patient. The nerve stimulator was set
at 1.5 mA, 2 Hz, 0.1 ms, and the needle was inserted through
the skin and propagated gradually in a cephalad direction at
a 45 angle to the skin surface while maintaining needle orien-
tation in a parasagittal plane till the femoral nerve was stimu-
lated resulting in contraction of the Quadriceps Femoris which
cause proximal patellar movement. The needle was positioned
to optimize the muscle contraction, and then the current was
decreased gradually until the best muscle contraction was ob-
tained at a current of 0.2–0.4 mA.
In group A, patients were injected with 20 ml Bupivacaine
0.25% and 5 ml of magnesium sulfate 10% solution (500 mg)
a total volume of 25 ml, through the needle directly on the
femoral nerve, While in group B, patients were injected with
20 ml Bupivacaine 0.25% and 5 ml normal saline 0.9%, a total
volume of 25 ml. All the patients enrolled in the study were
randomly assigned using concealed envelope method to one
of the two groups, in addition, patients as well as the anesthe-
tist and the surgeon were blinded to the type of the medica-
tions injected and the master codes were kept with a person
that does not share in the collection or analysis of the results.
The severity of pain was assessed using 10 mm linear Visual
analogue scale (VAS), where a score of 0 was considered as
pain free, while a score of 10 was considered as the worst imag-
inable pain. Pain was assessed at 1, 3, 6, 12, and 24 h postop-
eratively. Furthermore, the duration of action of Bupivacaine
was determined by assessing the sensory block at the antro-
medial aspect of the middle third of the thigh using pinprick
method compared with the same site in the contralateral thigh
as a reference, as well as, assessing the motor block of the
quadriceps muscle, both of which were recorded every
30 min. The duration of sensory block was considered as the
time interval between the local anesthetic injection and the
complete recovery of sensation, and the duration of motor
block was the time interval from local anesthetic injection till
the recovery of motor activity.
If the VAS pain scores recorded increases more than 5, Dic-
lofenac sodium 75 mg was administered IM as a rescue analge-
sic. The total dose of the Diclofenac sodium used was
recorded. Bearable pain period was measured and is deﬁned
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Figure 2 Pain scores as assessed by Visual analogue scale at 1, 3,
6, 12, and 24 h postoperatively for patients of both groups.
\Signiﬁcant difference.
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ied drug (Mg) during block placement till the ﬁrst injection of
the rescue analgesia. Side effects of Mg such as ﬂushing, seda-
tion, and decrease in mean blood pressure, or heart rate by
more than 15% of the initial baseline value were recorded at
the same time interval as done for the VAS.
Data were analyzed using computer statistical software sys-
tem SPSS version 12.0 (SPSS Inc., Chicago, IL, USA). Patient
characteristic data, operative time and time delay between
block placement and supplementary analgesic administration
were analyzed using two-tailed unpaired t-tests. Differences
between the groups in pain scores and total diclofenac con-
sumption were analyzed using Mann–Whitney U-test. The
number of patients requiring diclofenac was compared be-
tween groups using x2-test with Yates correction. Descriptive
data are expressed as mean (±SD). Sample size was estimated
using pain scores as the primary variable. Assuming a SD of
1 cm, we calculated a group size of 30 patients which would
be sufﬁcient to detect a difference of 1 cm on the VAS at an
alpha threshold of 0.007 with 90% power. A P-value lower
than 0.05 was considered statistically signiﬁcant.
3. Results
The current study showed no signiﬁcant differences in demo-
graphic data including sex, age, body weight or height between
group A and group B as shown in (Table 1). The mean dura-
tion of the surgical Laser Photocoagulation procedure was
close to each other in both groups, with no statistically signif-
icant difference (Table 1).
The duration of action of Bupivacaine as determined by
both the motor block and the sensory block which were as-
sessed every 30 min, was found to be signiﬁcantly longer in
group A i.e. with the addition of Mg than in group B as shown
in (Fig. 1).
As regards the severity of pain as assessed by VAS, the re-
sults were as follows; in group A at 1 h postoperatively
(1.5 ± 0.61), at 3 h (2.5 ± 0.49), at 6 h (2.9 ± 0.91), at 12 h
(3.2 ± 1.30), and ﬁnally at 24 h (1.1 ± 0.21), on the other
hand, in group B, at 1 h (7.8 ± 1.29), at 3 h (6.1 ± 1.01), at
6 h (5.9 ± 1.02), at 12 h (4.8 ± 0.12), and at 24 h
(4.2 ± 1.76), indicating a signiﬁcantly lower pain scores
among patients of group A as expressed in Fig. 2.
Bearable pain period was signiﬁcantly shorter in group B
(55 ± 11 min) when compared with that of group A
(672 ± 189 min) and this is expressed in Fig. 3, furthermore,
the total consumption of Diclofenac sodium in the 24 h post-
operatively was signiﬁcantly higher in group B
(113.6 ± 43.87 mg) than in group A (35.6 ± 39.15 mg) as
shown in Table 2.Table 1 Demographic and operative data. Values are expressed as
Group
Age (year) 31.6 ±
Gender (M/F) 9/21
Body weight (kg) 60 ± 30
Height (cm) 159 ± 3
Duration of surgery (min) 69 ± 25
No signiﬁcant differences between the two groups.4. Discussion
In the present study, we found that the use of Magnesium sul-
fate as an additive to the local anesthetic Bupivacaine during
peripheral nerve block improve postoperative pain score in pa-
tients undergoing laser photocoagulation surgery, with a long-
er duration of time till the need for a rescue analgesia and a
lower total dose of analgesics used, in addition, it prolongs
the duration of action of Bupivacaine.
Aiming for improvement and facilitation of fast rehabilita-
tion and recovery after surgery, our study was directed to-
wards better postoperative analgesia. Numerous clinical
investigations have demonstrated that Mg infusion duringmean ± SD.
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difference.
172 H.A. ELShamaa et al.general anesthesia reduces anesthetic requirement and postop-
erative analgesic consumption; in addition, its administration
also leads to a signiﬁcant reduction in analgesic consumption
during the intra-operative period [10–12]. The intrathecal as
well as the systemic administration of Magnesium sulfate im-
proves postoperative analgesia due to its antagonistic effect
on NMDA receptors [10,13,14], Moreover, postoperative anal-
gesic effect of Magnesium has been studied by many authors,
most of which showed in their studies that the systemic use of
Magnesium minimizes the postoperative analgesic requirement
and discomfort [15,16], so we were interested to determine
whether Magnesium can provide similar analgesia if injected
directly on the peripheral nerves during peripheral nerve block.
It is suggested that magnesium affects peripheral nerves as it
interferes with releasing neurotransmitters at the synaptic cleft
or potentiates local anesthetics action [17], besides, a potential
interaction between local anesthetics and high magnesium con-
centration in frog sciatic nerve block was suggested by Aku-
togawa et al. [18].
Supporting the results of the present study was the results
of Mizutani et al. [19], done on healthy adult volunteers to
study the analgesic effect of iontophoresis with Magnesium,
which showed a signiﬁcant prolongation of block duration
thus supporting the view that Magnesium has a good analgesic
effect resulting in a better pain relief clinically. Furthermore,
Aytac et al. [20], studied the duration of axillary plexus block
when Magnesium sulfate is added to Prilocaine, and concluded
that the use of magnesium with prilocaine during the blockTable 2 Total consumption of Diclofenac Sodium in the ﬁrst 24
requiring rescue analgesia. Values are expressed as mean ± SD.
Diclofenac sodium (mg)
Number of patients who needed rescue analgesia
* Indicates signiﬁcant differences between the two groups.causes a profound prolongation of both the motor and sensory
effect of prilocaine without side effects, suggesting that magne-
sium may be a useful adjuvant to local anesthetics. This goes
with the reported data that magnesium produces a state of gen-
eral anesthesia and promotes the activity of local anesthetic
agents [21]. Moreover, Elsharnouby et al. [22] reported a sig-
niﬁcant reduction in the total dose analgesia during their study
of the use of magnesium sulfate in hypotensive anesthesia.
Also, Hwang et al. [2], studied the use of magnesium during
spinal anesthesia to improve postoperative analgesia and re-
ported a signiﬁcant lowering in the VAS in patients receiving
magnesium during total knee replacement, but unlike the pres-
ent study no signiﬁcant differences were detected as regards the
need for postoperative rescue analgesia. On the contrary to our
study, Hung et al. [23] studied the effect of magnesium sulfate
on amide local anesthetics in rat sciatic nerve block and con-
cluded that magnesium shortens the duration of sciatic nerve
block with amide local anesthetics thus does not seem to be
useful adjuvant to local anesthetics in peripheral nerve block.
However, Bondok et al. [24] studied the effect of intra-articular
magnesium in knee arthroscopy, and showed that magnesium
resulted in a signiﬁcant decrease in the postoperative VAS in
the ﬁrst 24 h which become less signiﬁcant thereafter, in addi-
tion to, signiﬁcant decrease in the dose of postoperative rescue
analgesia with a longer delay in the need for that analgesia,
concluding that intra-articular magnesium can be a useful
alternative for postoperative analgesia. Furthermore, Kasheﬁ
et al. [25] studied the effect of adding magnesium to lidocaine
during intravenous regional anesthesia, and found out that
magnesium sulfate enhances the quality of anesthesia and
analgesia during regional intravenous anesthesia without caus-
ing side effects.
In conclusion, the results of this clinical study showed
that the admixture of magnesium sulfate to local anesthetic
bupivacaine during femoral nerve block provides a profound
prolongation of the duration of both sensory and motor
block, in addition to a signiﬁcant decrease in postoperative
pain scores and total dose of rescue analgesia, with a longer
bearable pain periods in the ﬁrst postoperative day. Further
studies are required to evaluate other doses, toxicity, and
other groups of local anesthetics, in addition to comparing
the effect of single perineural injection and perineural infu-
sion of magnesium on postoperative pain. Moreover, the
assessment of the results for a longer duration than the ﬁrst
postoperative day as well as in major surgical procedures
may be beneﬁcial.
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